NASC stock number: N72578
donor stock number: clv1-11 pUBQ::CLV1-2xGFP
Resource Type: seed
Availability: not available
Donors:- Elliot Meyerowitz
Donation Date: 08/05/2021
Date Released: 10/01/2021
Description:
Transgenic complementation line. pUBQ::CLV1-2xGFP construct expressed in the clv1-11 mutant background. clv1-11 plants were transformed by the floral dip method. Methotrexate resistant. Potentially segregating for the transgene.
Growth Requirement: none
Marker: kanamycin, methotrexate
Background: Ler (Landsberg erecta)
ABRC Comment:
Format Shipped: 100 seeds per vial
Base / Commercial Price: $15 / $120
Germplasm
2
complementation of clv1 carpel number defect
Arabidopsis thaliana 3702
Additional Information
| DOI | PubMed |
|---|---|
| 10.1016/j.cub.2011.01.039 | 21333538 |
| Transgene | Description | Promoter | Reporter | Marker |
|---|---|---|---|---|
| ETDs | enhancer trap transposon | -46 CaMV 35S | GUS | kanamycin |
| pUBQ::CLV1-2xGFP | genomic CLV1 fused at the C-terminus to two tandem copies of monomeric mGFP by a nine-alanine linker peptide, driven by the UBQ promoter | UBQ | 2xGFP | methotrexate |
Quality Control Comments
There is no quality control data for this stock.